During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
Guest Post by Barbara A. Conley, MD National Cancer Institute (NCI)
Bladder cancer is the fifth most common cancer in the United States, predominantly affecting men in the later decades...
Colorectal cancer screening prevented about 33,000 cases of colorectal cancer and saved the lives of about 16,000 U.S. residents...
Team up with AACR Runners for Research to raise awareness and funds for cancer research in our Halloween day...
The deadline to submit a Competitive Letter of Intent for the NextGen Grants for Transformative Cancer Research is Monday,...
China, a nation of 1.3 billion people, is facing an ongoing cancer epidemic, with more than 3 million people...
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...
Pediatric oncologist and precision medicine expert Andrew Kung, MD, PhD, of Columbia University explains.
Ductal carcinoma in situ (DCIS)—stage 0 breast cancer that starts in a duct and has not spread into surrounding...
Every year, the American Association for Cancer Research (AACR) organizes a robust program of educational workshops for early-career investigators...